EMEA-003640-PIP01-24
Submitted by Anonymous (not verified) on 26 June 2025 - 16:00
EMEA-003640-PIP01-24
Human medicines European public assessment report (EPAR): Kymriah, tisagenlecleucel, Date of authorisation: 23/08/2018, Revision: 22, Status: Authorised
Submitted by Anonymous (not verified) on 26 June 2025 - 15:45
Human medicines European public assessment report (EPAR): Kymriah, tisagenlecleucel, Date of authorisation: 23/08/2018, Revision: 22, Status: Authorised
EMEA-003582-PIP01-24
Submitted by Anonymous (not verified) on 26 June 2025 - 15:06
EMEA-003582-PIP01-24
EMEA-003577-PIP01-24
Submitted by Anonymous (not verified) on 26 June 2025 - 15:05
EMEA-003577-PIP01-24
EMEA-003581-PIP01-24
Submitted by Anonymous (not verified) on 26 June 2025 - 15:04
EMEA-003581-PIP01-24
EMEA-003525-PIP01-23
Submitted by Anonymous (not verified) on 26 June 2025 - 15:02
EMEA-003525-PIP01-23
EMEA-003463-PIP01-23
Submitted by Anonymous (not verified) on 26 June 2025 - 15:01
EMEA-003463-PIP01-23
EMEA-003459-PIP01-23
Submitted by Anonymous (not verified) on 26 June 2025 - 15:00
EMEA-003459-PIP01-23
Referral: Ipidacrine-containing medicinal products, ipidacrine Article 31 referrals Procedure started, 26/06/2025
Submitted by Anonymous (not verified) on 26 June 2025 - 14:58
Referral: Ipidacrine-containing medicinal products, ipidacrine Article 31 referrals Procedure started, 26/06/2025
Newsletters
Submitted by Anonymous (not verified) on 26 June 2025 - 14:57
Newsletters